The ingredient, which has been on the market for a number of years for use in supplements, is a water-dispersible curcuminoid complex. The company recently released research showing a 500 mg daily dose of the ingredient could relieve both gut discomfort and anxiety.
With the new regulatory status, the ingredient can now be used in yogurt, nutrition bars, smoothies, and other food and beverage products. The GRAS affirmation pertains to dosages of 40 mg to 60 mg per serving. The panel set the acceptable daily limit of Curcugen at 210 mg/day. Setting such daily limits is a standard part of the GRAS affirmation procedure. The company’s panel of experts also determined an upper limit up to 1400 mg/person/day in the same food formats which it considered was safe and meet the requirements of GRAS, as defined by the FDA.
Maintaining full spectrum of raw material
DolCas claims its production technology creates the dispersible form while at the same time maintaining the full spectrum of curcuminoids present in the raw material, which is the rhizomes of the turmeric plant. DolCas operates its own manufacturing arm in the Indian city of Bikaner, in the northwestern state of Rajasthan.
“In contrast to certain generic curcumin products currently on the market, our formulation preserves the original complex of curcuminoids, essential oils, and polar resins within the optimized oleoresin matrix,” said Dr Shavon Jackson-Michel, DolCas’ director of medical & scientific affairs.
“This supports its superior bioactive and holistic qualities,” she added.